GLP-2 Dual Agonist 30mg — Research Compound
GLP-2 is a synthetic dual-acting peptide that simultaneously targets both glucose-dependent insulinotropic polypeptide (GIP) receptors and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism has made it one of the most studied compounds in contemporary metabolic research, distinguishing it from single-pathway GLP-1 receptor agonists.
 
About GLP-2
By activating both GIP and GLP-1 receptors, this compound engages complementary metabolic pathways involved in insulin secretion, glucagon suppression, gastric emptying, and appetite regulation. Researchers have noted particular interest in the additive effects of dual receptor engagement compared to single-agonist approaches.
 
Current research has explored dual GIP/GLP-1 agonism in the following contexts:
Glucose homeostasis and insulin sensitivity
Appetite regulation and satiety signaling
Visceral adipose tissue reduction mechanisms
Cardiovascular risk marker modulation
Comparative efficacy versus single-pathway GLP-1 agonists
 
Product Specifications
Quantity: 30mg
Form: Lyophilized powder
Purity: ≥98% (HPLC verified)
Storage: Keep refrigerated at 2–8°C, protect from light
 
For Research Use Only. Not intended for human or veterinary use. This product is not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such.